Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 18;27(3):582.
doi: 10.3390/molecules27030582.

Antimicrobial Activity and DFT Studies of a Novel Set of Spiropyrrolidines Tethered with Thiochroman-4-one/Chroman-4-one Scaffolds

Affiliations

Antimicrobial Activity and DFT Studies of a Novel Set of Spiropyrrolidines Tethered with Thiochroman-4-one/Chroman-4-one Scaffolds

Nourhène Chouchène et al. Molecules. .

Abstract

A novel series of 14 spiropyrrolidines bearing thiochroman-4-one/chroman-4-one, and oxindole/acenaphthylene-1,2-dione moieties were synthesized and characterized by spectroscopic techniques, as well as by three X-ray diffraction studies, corroborating the stereochemistry. Quantum chemical calculations studies, using the DFT approach, were performed to rationalize the stereochemical outcome. These N-heterocycles were evaluated for their antibacterial and antifungal activities against some pathogenic organisms. Several compounds displayed moderate to excellent activity towards the screened microbe strains in the study compared to Amoxicillin (AMX), Ampicillin (AMP), and Amphotericin B. Furthermore, a structural activity relationship (SAR) was established considering the synthesized compounds. Pharmacokinetic studies reveal that these derivatives exhibit an acceptable predictive ADMET profile (Absorption, Distribution, Metabolism, Excretion and Toxicity) and good drug-likeness.

Keywords: DFT; [3+2] cycloaddition; chroman-4-one; crystal structure; spiropyrrolidine; thiochroman-4-one.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Biologically relevant thiochroman, thiochromanone, and chromanone derivatives, (C) Biologically relevant spiropyrrolidines bearing oxindole or acenaphthylene-1(2H)-one moieties, and (B) Our target compounds.
Scheme 1
Scheme 1
Synthesis scheme for the target compounds 4 and 9.
Figure 2
Figure 2
1H (black) and 13C {1H} NMR (green) chemical shifts (ppm) of the selected compound 4a (see also Figure S3 in the Supporting Material).
Figure 3
Figure 3
1H (black) and 13C {1H} NMR (green) chemical shifts (ppm) of the selected compound 9c (see also Figure S20 in the Supporting Material).
Figure 4
Figure 4
Ball and sticks presentation of the molecular structure of 4a recorded at 100 K. Only one of the two independent molecules is shown. Apart from stereochemically relevant H atoms, all other hydrogen atoms are omitted for clarity. Furthermore, an EtOH molecule of crystallization, present in the asymmetric unit, is not depicted.
Figure 5
Figure 5
Ball and sticks presentation of the molecular structure of 4e recorded at 100 K. Only stereochemically relevant H atoms are shown.
Figure 6
Figure 6
Ball and sticks presentation of the molecular structure of 9c recorded at 100 K. Only one of the two independent molecules is shown. Apart from stereochemically relevant H atoms, all other hydrogen atoms are omitted for clarity.
Scheme 2
Scheme 2
Proposed mechanism for the regio- and stereoisomeric 1,3-dipolar cycloaddition reaction of dipolarophile 1d with azomethine ylide d3.
Figure 7
Figure 7
Molecular electrostatic potential (MEP) formed by mapping of the total density over the electrostatic potential for compounds 4a, 4e, 4c, 9d, 9e, and 9f.

Similar articles

Cited by

References

    1. Tong S.Y.C., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G., Jr. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14. - DOI - PMC - PubMed
    1. Lowy F.D. Antimicrobial resistance: The example of Staphylococcus aureus. J. Clin. Investig. 2003;111:1265–1273. doi: 10.1172/JCI18535. - DOI - PMC - PubMed
    1. WHO Antimicrobial Resistance. 2018. [(accessed on 30 April 2014)]. Available online: www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
    1. Gurung R.R., Maharjan P., Chhetri G.G. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Future Sci. OA. 2020;6:FSO464. doi: 10.2144/fsoa-2019-0122. - DOI - PMC - PubMed
    1. Toumi A., Boudriga S., Hamden K., Sobeh M., Cheurfa M., Askri M., Knorr M., Strohmann B.C.L. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors. Bioorg. Chem. 2021;106:104507. doi: 10.1016/j.bioorg.2020.104507. - DOI - PubMed

MeSH terms

LinkOut - more resources